WO2010120133A2 - Phytoestrogen composition for preventing or relieving climacteric or menopausal symptoms - Google Patents

Phytoestrogen composition for preventing or relieving climacteric or menopausal symptoms Download PDF

Info

Publication number
WO2010120133A2
WO2010120133A2 PCT/KR2010/002349 KR2010002349W WO2010120133A2 WO 2010120133 A2 WO2010120133 A2 WO 2010120133A2 KR 2010002349 W KR2010002349 W KR 2010002349W WO 2010120133 A2 WO2010120133 A2 WO 2010120133A2
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
composition
present
preventing
relieving
Prior art date
Application number
PCT/KR2010/002349
Other languages
French (fr)
Korean (ko)
Other versions
WO2010120133A3 (en
Inventor
김재수
곽보연
이권택
이재경
Original Assignee
(주)내츄럴엔도텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)내츄럴엔도텍 filed Critical (주)내츄럴엔도텍
Publication of WO2010120133A2 publication Critical patent/WO2010120133A2/en
Publication of WO2010120133A3 publication Critical patent/WO2010120133A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a phytoestrogen composition for preventing or relieving climacteric or menopausal symptoms, wherein the phytoestrogen composition comprises at least one extract selected from the group consisting of lily, Cnidium monnieri (L.) Cusson, Polygala tenuifolia and mulberry root extracts as an active ingredient. The active ingredient of the present invention shows the activity of safe phytoestrogens through estrogen antagonistic and agonistic effects, thereby relieving or preventing various symptoms due to lack of estrogen during climacterium or menopause, and acts as an estrogen antagonist, thereby the problems of known hormone replacements seem not to occur. In addition, the active ingredient of the present invention hardly produces side effects in the human body since the active ingredient is a natural substance which has been used as medicine from the past to the present, thereby being capable of preparation as a pharmaceutical composition, a nutraceutical composition, or a food composition.
PCT/KR2010/002349 2009-04-15 2010-04-15 Phytoestrogen composition for preventing or relieving climacteric or menopausal symptoms WO2010120133A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0032821 2009-04-15
KR1020090032821A KR101087608B1 (en) 2009-04-15 2009-04-15 Phytoestrogen Composition for Preventing or Alleviating Climacteric or Menopausal Syndrome

Publications (2)

Publication Number Publication Date
WO2010120133A2 true WO2010120133A2 (en) 2010-10-21
WO2010120133A3 WO2010120133A3 (en) 2011-03-03

Family

ID=42983012

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/002349 WO2010120133A2 (en) 2009-04-15 2010-04-15 Phytoestrogen composition for preventing or relieving climacteric or menopausal symptoms

Country Status (2)

Country Link
KR (1) KR101087608B1 (en)
WO (1) WO2010120133A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101683344B1 (en) 2014-10-27 2016-12-07 숙명여자대학교산학협력단 Composition comprising carnosic acid for preventing or improving menopausal symptoms
JP6564134B2 (en) 2015-05-26 2019-08-21 ニュートゥリー カンパニー リミテッド A composition for preventing and treating muscular diseases or improving muscle function, comprising morsin, kwanonji or mulberry white skin
KR20160013227A (en) 2016-01-14 2016-02-03 김득수 Production method of young antler tea
KR20180098459A (en) * 2017-02-24 2018-09-04 한국 한의학 연구원 Pharmaceutical composition for preventing or treating cognitive impairment comprising extract of lily bulb
KR102075836B1 (en) 2018-05-31 2020-02-10 숙명여자대학교산학협력단 Composition for preventing or treating menopausal syndrome of women comprising Aristotelia chilensis extract, Angelica sinensis extract and Passiflora incarnata extract as an active ingredient

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343872A (en) * 2004-06-07 2005-12-15 Kao Corp Aromatase activator
WO2006065608A2 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Estrogenic extracts of morus alba and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343872A (en) * 2004-06-07 2005-12-15 Kao Corp Aromatase activator
WO2006065608A2 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Estrogenic extracts of morus alba and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHOI, SUN-YOUNG ET AL JOURNAL OF KOREAN SOCIETY OF FOOD SCIENCE AND TECHNOLOGY vol. 37, no. 4, 2005, pages 549 - 556 *
LIU, J.-X. ET AL CHINESE JOURNAL OF CLINICAL REHABILITATION vol. 9, no. 23, 2005, pages 186 - 189 *

Also Published As

Publication number Publication date
KR101087608B1 (en) 2011-11-29
WO2010120133A3 (en) 2011-03-03
KR20100114333A (en) 2010-10-25

Similar Documents

Publication Publication Date Title
Putnam et al. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health
Vikash et al. Piper betel Phytochemistry, traditional use & pharmacological activity a review
Shirwaikar et al. Medicinal plants for the management of post menopausal osteoporosis: A review
WO2010120133A2 (en) Phytoestrogen composition for preventing or relieving climacteric or menopausal symptoms
MX336861B (en) Abuse resistant drug formulation.
WO2008116890A3 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2011002223A3 (en) Composition for promoting adipocyte differentiation containing an extract of rehmannia glutinosa, licorice, coix lacryma-jobi seed, wheat germ, chaenomeles sinensis fruit, acanthopanacis cortex or radix puerariae
WO2011043631A3 (en) Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound
UA103347C2 (en) Pharmaceutical dosage form comprising nifedipine or nisoldipine and angiotensin-ii antagonist and/or diuretic
WO2009026473A3 (en) Stabilized therapeutic compositions and formulations
WO2011159100A3 (en) Anti-cancer pharmaceutical composition
WO2011059292A3 (en) Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects
Bakhsh et al. Catechin-rich oil palm leaf extract enhances bone calcium content of estrogen-deficient rats
Palmeira-de-Oliveira et al. Are plant extracts a potential therapeutic approach for genital infections?
WO2005065639A3 (en) Novel pharmaceutical compositions
WO2012050397A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer
ES2325291A1 (en) Use of a silybum marianum extract
WO2011052935A3 (en) Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient
Sangi et al. Hepatoprotective effects of oleuropein, thymoquinone and fruit of phoenix dactylifera on CCl 4 induced hepatotoxicity in rats
WO2011141113A3 (en) Combination of vitamin k and nicotinamide
CA2756742A1 (en) Composition for prevention or treatment of insomnia
WO2008120542A1 (en) Food composition having the form of solid preparation comprising plant polygonum aviculare as active ingredient
WO2012048446A8 (en) New use of chemical ingredients in cynomorium as phytoestrogen
Jain et al. A Novel Natural Product for Bone Regeneration in Dentistry--A Review.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10764672

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10764672

Country of ref document: EP

Kind code of ref document: A2